← Leaderboards
Susan M Chang
University Of California San Francisco
$13,274,374
Attributed
$15,356,856
Total exposure
18
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,549,730 · 20
By mechanism
P01$34,861,952 · 10
P50$3,652,299 · 3
U54$2,686,502 · 2
R01$2,598,382 · 1
P30$1,037,365 · 2
U01$687,291 · 1
Top collaborators
- Daniel B Vigneron14 shared
- Sarah J. Nelson5 shared
- Albert Chen4 shared
- Yan Li4 shared
- Duan Xu4 shared
- Janine Marie Lupo2 shared
- Franklin W Huang1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Frank Patrick McCormick$56,513,144
- Mitchel S. Berger$12,317,215
- Michael D Prados$7,364,703
- Katherine Kurshan Matthay$7,757,759
- Soonmee Cha$807,030
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageTissuesGrantEvaluationTumorProgramsGliomaMonitorNeuro-OncologyDesignGlioblastomaProtocols DocumentationBiological MarkersClinical TrialsCharacteristicsResponseClinical ResearchMetabolicPropertyResourcesResearch PersonnelBiologicalBrain NeoplasmsMolecular
Grant awards (85)
Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management$2,654,906
P01 · FY2025 · CA · contact PI
Interplay of tumor genomic and immune characteristics and external drivers of health to improve cancer health outcomes$2,520,895
U54 · FY2025 · CA · contact PI
Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma$660,633
R01 · FY2025 · CA
Project 2: Novel hyperpolarized C-13 imaging as metabolic markers of response in IDH mutant glioma$424,727
P50 · FY2025 · CA · contact PI
Core A: Administrative and Clinical Services Core (ACS)$241,963
P01 · FY2025 · CA · contact PI
Neurologic Oncology Program$185,525
P30 · FY2025 · CA · contact PI
Core A: Administrative Core$165,607
U54 · FY2025 · CA · contact PI
Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management$2,654,906
P01 · FY2024 · CA · contact PI
Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma$627,567
R01 · FY2024 · CA
Project 2: Novel hyperpolarized C-13 imaging as metabolic markers of response in IDH mutant glioma$409,607
P50 · FY2024 · CA · contact PI
Core A: Administrative and Clinical Services Core (ACS)$241,963
P01 · FY2024 · CA · contact PI
Neurologic Oncology Program$183,261
P30 · FY2024 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,382,735
P01 · FY2023 · CA · contact PI
Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma$648,493
R01 · FY2023 · CA
Project 2: Novel hyperpolarized C-13 imaging as metabolic markers of response in IDH mutant glioma$405,940
P50 · FY2023 · CA · contact PI
Administrative and Clinical Services Core$210,508
P01 · FY2023 · CA · contact PI
Neurologic Oncology Program$183,249
P30 · FY2023 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$85,963
P01 · FY2023 · CA · contact PI
Admin-Core-001$84,577
P01 · FY2023 · CA · contact PI
Administrative and Clinical Services Core$12,280
P01 · FY2023 · CA · contact PI
Admin-Core-001$12,280
P01 · FY2023 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,278,799
P01 · FY2022 · CA · contact PI
Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma$661,689
R01 · FY2022 · CA
Administrative and Clinical Services Core$204,506
P01 · FY2022 · CA · contact PI
Core 2: Biostatistics/Clinical$149,999
P50 · FY2022 · CA · contact PI
Neurologic Oncology Program$87,279
P30 · FY2022 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$85,963
P01 · FY2022 · CA · contact PI
Administrative and Clinical Services Core$85,963
P01 · FY2022 · CA · contact PI
Admin-Core-001$82,817
P01 · FY2022 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,277,604
P01 · FY2021 · CA · contact PI
Administrative and Clinical Services Core$214,832
P01 · FY2021 · CA · contact PI
Core 2: Biostatistics/Clinical$149,998
P50 · FY2021 · CA · contact PI
Neurologic Oncology Program$122,428
P30 · FY2021 · CA · contact PI
Admin-Core-001$87,717
P01 · FY2021 · CA · contact PI
Diversity Supplement: 5P01CA118816 Project 1$87,717
P01 · FY2021 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,238,345
P01 · FY2020 · CA · contact PI
Administrative and Clinical Services Core$214,230
P01 · FY2020 · CA · contact PI
Core 2: Biostatistics/Clinical$147,333
P50 · FY2020 · CA · contact PI
Neurologic Oncology Program$79,592
P30 · FY2020 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,157,708
P01 · FY2019 · CA · contact PI
Administrative and Clinical Services Core$210,621
P01 · FY2019 · CA · contact PI
Core 2: Biostatistics/Clinical$141,632
P50 · FY2019 · CA · contact PI
Neurologic Oncology Program$86,716
P30 · FY2019 · CA · contact PI
Core 2: Biostatistics/Clinical$161,094
P50 · FY2018 · CA · contact PI
Neurologic Oncology Program$86,469
P30 · FY2018 · CA · contact PI
Neurologic Oncology Program$10,743
P30 · FY2018 · CA · contact PI
Neurologic Oncology Program$8,603
P30 · FY2018 · CA · contact PI
Neurologic Oncology Program$3,500
P30 · FY2018 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,175,899
P01 · FY2017 · CA · contact PI
NOVEL BIOMARKERS OF MALIGNANT PROGRESSION IN RECURRENT LOW GRADE GLIOMA$344,796
P50 · FY2017 · CA · contact PI
Biospecimen and Biostatistics Core$311,904
P01 · FY2017 · CA · contact PI
Imaging Core$270,933
P01 · FY2017 · CA · contact PI
Administrative and Clinical Services Core$224,780
P01 · FY2017 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,170,035
P01 · FY2016 · CA · contact PI
Imaging Core$333,611
P01 · FY2016 · CA · contact PI
NOVEL BIOMARKERS OF MALIGNANT PROGRESSION IN RECURRENT LOW GRADE GLIOMA$316,438
P50 · FY2016 · CA · contact PI
Biospecimen and Biostatistics Core$301,764
P01 · FY2016 · CA · contact PI
Administrative and Clinical Services Core$210,859
P01 · FY2016 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,180,843
P01 · FY2015 · CA · contact PI
Biospecimen and Biostatistics Core$353,004
P01 · FY2015 · CA · contact PI
NOVEL BIOMARKERS OF MALIGNANT PROGRESSION IN RECURRENT LOW GRADE GLIOMA$340,705
P50 · FY2015 · CA · contact PI
Imaging Core$260,105
P01 · FY2015 · CA · contact PI
Administrative and Clinical Services Core$217,863
P01 · FY2015 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,101,713
P01 · FY2014 · CA · contact PI
Biospecimen and Biostatistics Core$341,630
P01 · FY2014 · CA · contact PI
NOVEL BIOMARKERS OF MALIGNANT PROGRESSION IN RECURRENT LOW GRADE GLIOMA$325,902
P50 · FY2014 · CA · contact PI
Imaging Core$251,724
P01 · FY2014 · CA · contact PI
Administrative and Clinical Services Core$210,843
P01 · FY2014 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,138,843
P01 · FY2013 · CA · contact PI
Program as an Integrated Effort$376,326
P01 · FY2013 · CA · contact PI
NOVEL BIOMARKERS OF MALIGNANT PROGRESSION IN RECURRENT LOW GRADE GLIOMA$334,128
P50 · FY2013 · CA · contact PI
Progress During the Current Funding Period$263,474
P01 · FY2013 · CA · contact PI
Administrative and Clinical Services Core$212,045
P01 · FY2013 · CA · contact PI
Intedrated Imagaing and Tissue Biomarkers in Glioblastoma Multiforme Post Therapy$240,918
P01 · FY2011 · CA · contact PI
Intedrated Imagaing and Tissue Biomarkers in Glioblastoma Multiforme Post Therapy$248,298
P01 · FY2010 · CA · contact PI
Intedrated Imagaing and Tissue Biomarkers in Glioblastoma Multiforme Post Therapy$223,194
P01 · FY2009 · CA · contact PI
Intedrated Imagaing and Tissue Biomarkers in Glioblastoma Multiforme Post Therapy$212,875
P01 · FY2008 · CA · contact PI
NABTC Member Intitution Grant (UCSF Project Leader)$138,276
U01 · FY2008 · CA · contact PI
Intedrated Imagaing and Tissue Biomarkers in Glioblastoma Multiforme Post Therapy$219,566
P01 · FY2007 · CA · contact PI
NABTC Member Intitution Grant (UCSF Project Leader)$130,922
U01 · FY2007 · CA · contact PI
NABTC Member Intitution Grant (UCSF Project Leader)$139,768
U01 · FY2006 · CA · contact PI
NABTC Member Intitution Grant (UCSF Project Leader)$140,460
U01 · FY2005 · CA
CCI-779 IN PATIENTS WITH MALIGNANT GLIOMA$15,900
M01 · FY2005 · RR
NABTC Member Intitution Grant (UCSF Project Leader)$137,865
U01 · FY2004 · CA
CCI-779 in Patients with Malignant Glioma$10,039
M01 · FY2004 · RR